T-cell therapy may aid in antiphospholipid syndrome through selective B-cell depletion

PHILADELPHIA — Upcoming T-cell therapies may treat antiphospholipid syndrome and other autoimmune diseases without compromising a patient’s defenses against infection, according to data presented at ACR Convergence 2022.

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Byerich Martin ,Maximilianf Konig ,Shenaz Bagha ,Johns Hopkins University School Of Medicine ,Upcomingt Cell ,Johns Hopkins University School ,